Načítá se...
Advances in targeted therapy for malignant lymphoma
The incidence of lymphoma has gradually increased over previous decades, and it ranks among the ten most prevalent cancers worldwide. With the development of targeted therapeutic strategies, though a subset of lymphoma patients has become curable, the treatment of refractory and relapsed diseases re...
Uloženo v:
| Vydáno v: | Signal Transduct Target Ther |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group UK
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7058622/ https://ncbi.nlm.nih.gov/pubmed/32296035 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41392-020-0113-2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|